Your session is about to expire
← Back to Search
Reimbursement Strategies for Breast Cancer
N/A
Waitlist Available
Led By Courtney Williams, DrPH
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
This trial aims to identify a financial reimbursement amount that compensates for trial-incurred expenses while minimizing financial toxicity for women with breast cancer in clinical trials.
Who is the study for?
This trial is for women with breast cancer who are already part of the I-SPY TRIAL 2 at UAB Medical Oncology Clinic. It's not open to men, non-English speakers, or female patients not enrolled in I-SPY TRIAL 2.Check my eligibility
What is being tested?
The study is testing different amounts of money given back to participants to cover costs related to being in a clinical trial. The goal is to find out what amount feels right and helps reduce financial stress from these expenses.See study design
What are the potential side effects?
Since this trial involves financial reimbursement rather than medical treatment, there aren't any direct physical side effects. However, it will assess how receiving money affects participants' feelings about their financial burden.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of patients who receive all reimbursements and who complete follow-up surveys (overall feasibility of intervention)
Trial Design
1Treatment groups
Experimental Treatment
Group I: Patients receiving reimbursementExperimental Treatment1 Intervention
Monthly reimbursement to offset trial-related expenses
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,583 Previous Clinical Trials
2,280,014 Total Patients Enrolled
31 Trials studying Breast Cancer
4,461 Patients Enrolled for Breast Cancer
Courtney Williams, DrPHPrincipal InvestigatorUniversity of Alabama at Birmingham
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a woman with breast cancer participating in the I-SPY TRIAL 2 at UAB.I am a female cancer patient not participating in the I-SPY TRIAL 2.I am a female and I do not have cancer.I am male.
Research Study Groups:
This trial has the following groups:- Group 1: Patients receiving reimbursement
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies for this trial's participants?
"According to clinicaltrials.gov the trial is not currently enrolling new patients, as it was last updated on July 6th 2023. This does not mean that you cannot take part in a medical study though; there are still 1471 trials actively searching for volunteers at this time."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger